Remedy Meds to acquire Thirty Madison for $500m.

Remedy Meds, a consumer virtual-care and pharmacy platform, agreed to acquire Thirty Madison, a hospital, health care, and medical practice company, for $500m. "By bringing together Thirty Madison's trusted brands with Remedy Med's acquisition engine, retention system, and pharmacy infrastructure, we will broaden access, shorten time-to-treatment, and maintain the financial discipline that has defined our growth," Haris Memon, Remedy Meds Founder and CEO.